Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia.
The purpose of this study was to investigate whether alpha-lipoic acid (LA), the oxidized form of the radical scavenger dihydrolipoic acid (DLA), protected brain tissue against ischemic damage and whether there were differences in the neuroprotective potencies between its enantiomers. We used the models of focal cerebral ischemia in mice and rats. The infarct area on the mouse brain surface and the infarct volume of the rat brain were determined by means of an image analyzing system. The LA was capable of reducing the infarct area only when it was administered subcutaneously, but not when it was administered intraperitoneally or into the cisterna magna. Both the R- and the S-enantiomer of LA protected brain tissue against ischemic damage, but their protective activities seemed to be related to the time period of pretreatment. In mice, both enantiomers revealed a similar neuroprotective potency when they were administered subcutaneously 1 or 2 hr before occlusion of the middle cerebral artery (MCA), whereas a longer time period of pretreatment (4 or 6 hr) failed to exert neuroprotection. In rats, subcutaneous pretreatment with R- or S-LA for 2 hr before ischemia significantly diminished the infarct volume. We assume that LA has to be reduced to DLA which finally causes neuroprotection.
Wolz
P
P
Institute für Pharmakologie und Toxikologie, Philipps-Universität, Marburg, Germany.
Krieglstein
J
J
D000818:Animals; D001921:Brain / Q000473:pathology*; D002545:Brain Ischemia / Q000188:drug therapy*; D002544:Cerebral Infarction / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D051379:Mice; D051381:Rats; D017207:Rats, Sprague-Dawley; D013237:Stereoisomerism; D008063:Thioctic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D008063:Thioctic Acid